What zoledronic acid is, who it's for, and what an infusion day actually looks like. If your doctor said Reclast, this is the same medication. Written for patients and caregivers in Maryland.
Zoledronic acid is an infused osteoporosis medication, and it is the generic form of the brand you may have heard called Reclast. It slows the cells that break bone down, which lets the rebuilding side keep up. For treating osteoporosis the dose is 5 mg once a year, and the medication runs for at least 15 minutes. One appointment, then nothing to remember until next year, which is why many people move to it after struggling with a daily or weekly pill. Springside administers zoledronic acid in Columbia, Bowie, and Frederick, Maryland. Your prescriber keeps managing your bone health. We handle the infusion, the insurance authorization, and the paperwork.
Zoledronic acid and Reclast are the same medication. Reclast is the brand name. Zoledronic acid is the drug itself, and it is what you will see on your bottle of paperwork, your explanation of benefits, and your appointment reminder. Same 5 mg dose, same 100 mL bag, same schedule.
It belongs to a family of medications called bisphosphonates. Alendronate and risedronate are in the same family and are usually taken as pills. Zoledronic acid is the one given into a vein.
One caution on names: zoledronic acid is also sold as Zometa at a different dose for cancer-related bone problems. If you are already receiving Zometa, you should not also receive this. Tell your prescriber and tell us.
Bone is not a finished object. It is torn down and rebuilt constantly, by two crews working against each other. Osteoclasts break old bone away. Osteoblasts lay new bone down. In osteoporosis the breaking-down crew outpaces the building crew, and what is left behind is thinner and easier to fracture.
Zoledronic acid is antiresorptive, which means it works on the first crew rather than the second. It binds to the mineral surface of bone and interferes with the osteoclasts that land there, so less bone gets stripped away.
It does not rebuild a skeleton you have already lost density from. What it aims to do is stop the loss and lower the chance of a fracture.
That binding is also why one infusion covers a year. The medication settles into bone and keeps working there long after the bag is empty.
Zoledronic acid at this dose is FDA-approved for:
There are people it is not for. It should not be given if your blood calcium is low until that is corrected, if you have had an allergic reaction to zoledronic acid before, or if your kidney function is below the threshold on the label. Kidney function is calculated before every dose, not just the first one.
The label also says something patients rarely hear: people at low risk of fracture should be considered for stopping the drug after three to five years. This is not a medication you are automatically on forever, and it is a fair question to put to your prescriber.
Your prescriber decides whether zoledronic acid is appropriate. This page explains what the treatment involves once they have.
The dose is 5 mg in 100 mL, given into a vein over no less than 15 minutes at a steady rate through its own line. How often you come back depends on why you are taking it.
Drink fluids. The label requires that you be properly hydrated before the infusion, and it matters for your kidneys. Do not skip breakfast or arrive dry after a morning of errands. If you have been told to limit fluids for another condition, call us before your appointment and we will sort out what to do.
Take your calcium and vitamin D. Adequate calcium and vitamin D go alongside this treatment. Your prescriber will tell you the amounts that apply to you.
Exact doses and timings come from your prescriber. The schedule above is the standard pattern, not a substitute for the plan they write.
Each links to its condition guide, where you’ll find the other infusion medications used to treat it.
The infusion is short. The visit is longer than the infusion, and the day after matters more than the day itself. Here is the shape of a typical visit.
Plan the next two days, not just the appointment. A flu-like reaction in the first three days after the infusion is common enough that you should expect the possibility rather than be blindsided by it. Keep drinking fluids, and ask your prescriber ahead of time about taking acetaminophen afterward, which the label notes may reduce those symptoms. Do not schedule your infusion the day before something you cannot miss.
The thing most people notice is the acute phase reaction, and it is the single most common reason patients dread a second infusion.
It feels like coming down with flu. Fever, aching muscles, joint pain, headache, tiredness, sometimes nausea. In the trials, these symptoms mostly turned up in the first three days after the dose and usually cleared within three days of starting, though for some people it took up to one to two weeks.
It is unpleasant and it is not a sign the medication is harming you. Talk to your prescriber about acetaminophen before your infusion day so you are not making that decision while you feel awful.
Patients ask about the jaw more than anything else on this page, usually after reading something frightening online.
Here is what the label says. Osteonecrosis of the jaw has been reported in people taking bisphosphonates. The label directs your prescriber to perform a routine oral examination before you start treatment. Risk is higher for people with cancer, chemotherapy or radiotherapy, steroid treatment, poor oral hygiene, or existing dental disease or infection.
What to do with that: tell your dentist you are on zoledronic acid, tell your prescriber about dental work you have planned, especially extractions or implants, and keep up routine cleanings. Report jaw pain, a loose tooth, or gum swelling that will not settle. Do not stop treatment on your own because of something you read. Bring it to the prescriber who ordered it.
Tell us at check-in if you had a reaction to a previous infusion, feel unwell that day, have started a new medication, or have dental work coming up.
You can change where you receive your zoledronic acid infusions without changing your prescriber. Your endocrinologist, rheumatologist, or primary care physician continues to manage your bone health and writes the order. We administer the infusion and report back to them.
Many Maryland insurance plans now prefer, and some require, that non-urgent infusions be given at an ambulatory infusion center rather than a hospital outpatient department, often at meaningfully lower out-of-pocket cost. Coverage rules and prior-authorization requirements vary by plan, so we verify your benefits and handle the authorization before your first visit.
Please include the following with your referral:
